Breast Cancer | Dr. Tony Talebi discusses the Treatment of Locally ...

Dr. Tony Talebi discusses the Treatment of Locally Advanced Stage 1 to 3 Estrogen Receptor Positive Breast Cancer with Dr. Lippman. For further discussion visit www.HemOnc101.com Treatment of locally advanced stage 1 to 3 estrogen receptor positive breast cancer Breast cancer is the most common female cancer in the US. Important risk factors for breast cancer are age, gender, reproductive history, hormonal factors, and family history. Although a family history of breast and ovarian cancer is common in patients diagnosed with breast cancer, less than ten percent of all breast cancers are associated with genetic mutations. Assay of hormone receptors (estrogen [ER] and progesterone [PR] receptors) is an important component of the pathologic evaluation of breast cancer, for both prognostic and predictive purposes, as patients with hormone receptor-positive tumors benefit from the addition of endocrine treatments. The treatment of early stage breast cancer includes the treatment of locoregional disease with surgery, radiation therapy, or both, and the treatment of systemic disease with one or a combination of chemotherapy, endocrine therapy, or biologic therapy. Here, Dr. Tony Talebi discusses the treatment of locally advanced stage 1 to 3 estrogen receptor positive breast cancer with world renowned breast cancer expert Dr. Marc Lippman, professor and chairman of the department of medicine at the University of Miami. Dr. Marc Lippman pioneered the use of tamoxifen in estrogen ?

This entry was posted on Tuesday, March 13th, 2012 at 4:42 am and is filed under Treatment. You can follow any responses to this entry through the RSS 2.0 feed. Responses are currently closed, but you can trackback from your own site.

Source: http://icanfixthis.info/breast-cancer-dr-tony-talebi-discusses-the-treatment-of-locally-advanced-er-breast-cancer

obscura grok cirque du freak eric cantor eric cantor the beach paul pierce